Diethylene Glycol (DEG) Residue Quantitative Analysis Methods: Techniques, Standards, and Applicatio

Diethylene glycol (DEG) residue quantitative analysis is a critical quality and safety control for pharmaceuticals, glycerin-based excipients, cosmetics, and polymer materials. This article explains the principal analytical techniques, including GC-FID, GC-MS, and HPLC-RID, together with applicable pharmacopoeial and international standards, typical sample types, method validation parameters, and frequently asked questions. It serves as a practical technical reference for manufacturers and accredited third-party laboratories.

Technical Overview

Diethylene glycol (DEG; CAS 111-46-6; molecular formula C4H10O3; molecular weight 106.12) is a colorless, hygroscopic, water-miscible diol with a boiling point of approximately 245 degrees Celsius. DEG ingestion is hazardous because its acidic metabolites cause acute kidney injury, central nervous system depression, metabolic acidosis, and hepatic damage, and DEG contamination has been responsible for multiple fatal mass-poisoning incidents involving oral liquid medications, toothpaste, and other consumer products worldwide.

DEG enters products through several routes: as a by-product of monoethylene glycol (MEG) production from ethylene oxide hydrolysis; as an impurity or deliberate adulterant in glycerin derived from biodiesel-related transesterification processes; as a co-monomer by-product formed during PET polycondensation, where DEG content also serves as a process quality indicator; and as a residual humectant or solvent carried over from formulation steps. The United States Pharmacopeia (USP) Glycerin monograph and General Chapter <425> limit DEG and ethylene glycol (EG) to not more than 0.1 percent, and equivalent requirements appear in the European Pharmacopoeia and the Chinese Pharmacopoeia. Quantitative methods must therefore be specific, sensitive, and validated well into the low ppm range.

Testing Samples

Pharmaceutical Raw Materials and Excipients

Glycerin (glycerol), propylene glycol, polyethylene glycols, and sorbitol solution represent the highest-risk materials and are routinely tested lot by lot in accordance with pharmacopoeial requirements.

Finished Pharmaceutical Products

Oral liquid preparations such as cough syrups, antipyretic and analgesic suspensions, elixirs, and glycerin-based suppositories, where DEG may be introduced through contaminated excipients.

Cosmetics and Personal Care Products

Toothpaste, mouthwash, and humectant-containing creams and lotions, reflecting lessons learned from historical adulteration cases.

Food and Related Consumer Products

Glycerin used as a food additive (E422), flavor and fragrance concentrates, and glycerin-based electronic cigarette liquids.

Polymer and Industrial Chemical Materials

PET chips, fibers, and films (DEG content typically 1 to 3 percent as a process parameter), industrial monoethylene glycol, antifreeze and coolant concentrates, and brake fluids.

Sample Submission Requirements

• Liquid samples: typically 5 to 10 grams (or milliliters) per test, sealed in airtight glass containers to prevent volatile loss.
• Solid and semi-solid samples: 10 to 20 grams, protected from moisture uptake.
• Complete matrix declaration and chain-of-custody documentation to support appropriate method selection.

Testing Items

• Diethylene glycol (DEG) residual content, reported in ppm or percent by weight.
• Ethylene glycol (EG) content, commonly determined together with DEG in a single chromatographic run.
• Triethylene glycol (TEG) and related glycol impurities.
• Total glycol impurity profiling for MEG purity and glycerin quality assessment.
• Method validation parameters: specificity, linearity, limit of detection (LOD), limit of quantification (LOQ), accuracy (recovery), precision, and robustness.

Testing Methods

Gas Chromatography with Flame Ionization Detection (GC-FID)

GC-FID is the primary pharmacopoeial quantitative technique. Samples are diluted in a suitable solvent such as water, methanol, or acetonitrile and injected directly onto a polar capillary column, while a diol internal standard such as 1,3-propanediol or 1,4-butanediol compensates for injection variability. Typical LOQ values of 10 to 50 ppm comfortably support the 0.1 percent (1000 ppm) pharmacopoeial limit.

Gas Chromatography-Mass Spectrometry (GC-MS)

GC-MS provides confirmation of identity and trace-level quantification in complex matrices using selected-ion monitoring of DEG characteristic fragments. An LOQ of 1 to 10 ppm is achievable, and derivatization such as silylation can further improve sensitivity and peak shape where required. GC-MS forms the identification arm of USP General Chapter <425>.

High Performance Liquid Chromatography (HPLC-RID/ELSD)

HPLC with refractive index or evaporative light scattering detection offers an alternative for thermally labile or non-volatile matrices, and is well suited to samples with a high glycerin background when separation is achieved on carbohydrate or ion-exclusion columns.

Rapid Screening Techniques

High-performance thin-layer chromatography (HPTLC) provides a low-cost screening option for DEG and EG in glycerin and syrup matrices, allowing suspect samples to be routed to GC-MS confirmation.

Polymer-Specific Determination

DEG content in PET is quantified by proton nuclear magnetic resonance (1H-NMR) spectroscopy or by GC analysis following methanolysis or aminolysis depolymerization, supporting control of fiber dyeability, melting behavior, and thermal properties.

Governing Standards and Validation

• USP General Chapter <425> (Diethylene Glycol/Ethylene Glycol) and the USP Glycerin monograph.
• European Pharmacopoeia and Chinese Pharmacopoeia glycerol monographs with GC-based limit tests.
• ASTM E2409 covering the determination of DEG and EG in monoethylene glycol by gas chromatography.
• Method validation performed in accordance with ICH Q2 analytical procedure validation guidelines.

Applications

• Lot release testing and incoming material qualification of glycerin and polyol excipients by pharmaceutical and cosmetic manufacturers.
• Regulatory compliance and export clearance, including responses to WHO and national authority safety alerts.
• Root-cause investigation and forensic analysis following contamination events or adverse reaction reports.
• PET polymerization process control and fiber or film quality assessment through DEG content monitoring.
• MEG production purity control and antifreeze and brake fluid quality verification.
• Supplier audits and contractual specification verification performed by accredited third-party laboratories.

FAQ

What regulatory limit applies to DEG residues?

Pharmacopoeial monographs for glycerin typically limit DEG to not more than 0.1 percent (1000 ppm). Finished oral liquid products are frequently controlled to much lower, dose-dependent levels specified by national regulatory authorities, which is why ppm-level GC-MS methods are often required.

Can DEG and ethylene glycol be quantified in a single analysis?

Yes. GC-FID and GC-MS methods separate EG, DEG, and related glycols in one chromatographic run, which is why pharmacopoeial limit tests address these impurities together.

What detection limits can be achieved?

Typical LOQ values are approximately 10 to 50 ppm by GC-FID and 1 to 10 ppm by GC-MS, depending on the matrix. Derivatization can extend GC-MS sensitivity below 1 ppm when necessary.

How much sample is required and what is a typical turnaround time?

Generally 5 to 10 grams of liquid or 10 to 20 grams of solid sample is sufficient. Routine testing is commonly completed within five to seven working days, while method development for unusual matrices requires additional time.

Why is headspace GC not routinely used for DEG?

The low volatility of DEG (boiling point approximately 245 degrees Celsius) makes headspace sampling inefficient. Direct liquid injection, or derivatization to more volatile derivatives, provides significantly better sensitivity and quantitative accuracy.